Testing effectiveness (Phase 2)Study completedNCT01587079
What this trial is testing
Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Who this might be right for
Chronic Obstructive Pulmonary Disease
Pearl Therapeutics, Inc. 159